Wedbush Maintains Outperform on Solventum, Raises Price Target to $101

سولفنتوم

Solventum Corporation

SOLV

0.00

Wedbush analyst Michael Piccolo maintains Solventum (NYSE: SOLV) with a Outperform and raises the price target from $94 to $101.